Abstract: A method for preparing Portland cement includes: respectively weighing iron slag, copper slag, vanadium slag, and nickel slag and grinding, to yield prefabricated iron slag, prefabricated copper slag, prefabricated vanadium slag, and prefabricated nickel slag; weighing mica and kaolinite, mixing, and grinding to obtain aluminous raw materials; evenly mixing the prefabricated iron slag and the aluminous raw materials, and calcining, to yield an iron-aluminum eutectic mineral; weighing the marble, fluorite, dolomite, and quartz, evenly mixing the marble, fluorite, dolomite, and quartz with the prefabricated copper slag, prefabricated vanadium slag, and prefabricated nickel slag to yield a first mixture; grinding the iron-aluminum eutectic mineral to yield powders, and calcining a second mixture of the first mixture and the powders, to yield the cement clinker; and cooling the cement clinker, and grinding a third mixture of the cooled cement clinker and the gypsum, to yield the Portland cement.

Abstract: An adaptive characteristic spectral line screening method and system based on atomic emission spectrum are provided, the method includes: using a set characteristic screening optimization method to perform a plurality of optimization rounds of characteristic screening, obtaining an initialized spectral dataset of each round of the characteristic screening and initialized characteristic population genes; obtaining an optimal characteristic population gene of each round by a set analysis method, a fitness function, and an iteration of a genetic algorithm; obtaining an optimized characteristic spectral information set when the plurality of optimization rounds reach set optimization rounds; performing combination statistics and discriminant analyses on the optimized characteristic spectral information set to complete an adaptive characteristic spectral line screening.

Abstract: Provided here are compositions and methods of preventing or treating a muscle disorder in a subject, such as muscle wasting, cachexia, sarcopenia and heart failure. The compositions include inhibitors targeting one or more of the H19X-encoded non-coding RNAs. The inhibitors can inhibit expression of one or more of the H19X-encoded non-coding RNAs or inhibit interaction between one or more of the H19X-encoded non-coding RNAs and their natural target mRNA. Also, provided are methods of preventing or treating a muscle disorder in a subject by inducing specific mutations to decrease levels of one or more of the H19X-encoded non-coding RNAs utilizing gene editing tools such as, but not limited to, integrases, CRISPR/Cas nucleases, TALAN nucleases, zinc finger Nucleases, triplex forming oligonucleotides, or combinations thereof.

Abstract: The present disclosure describes the role for miR-322(424)/503 in the differentiation of cardiac precursor cells. Thus, the use of these molecules in the programming of resident stem/progenitor cells into cardiomyocytes, both in vitro and in vivo. Such methods find particular use in the treatment of patients post-myocardial infarction to prevent or limit scarring and to promote myocardial repair.

Abstract: According to an example, a first terminal device uploads sharing information to a server, the server sends identification information related to the sharing information to the first terminal device according to the sharing information, and the first terminal device transforms the identification information into a sound signal, and plays the sound signal. a second terminal device receives the sound signal, parses the sound signal to obtain the identification information, and sends a download request comprising the identifier information to the server. The server sends the sharing information to the second terminal device according to the download request.

Abstract: The present disclosure describes the role for miR-322(424)/503 in the differentiation of cardiac precursor cells. Thus, the use of these molecules in the programming of resident stem/progenitor cells into cardiomyocytes, both in vitro and in vivo. Such methods find particular use in the treatment of patients post-myocardial infarction to prevent or limit scarring and to promote myocardial repair.

Abstract: The present disclosure describes the role for miR-322(424)/503 in the differentiation of cardiac precursor cells. Thus, the use of these molecules in the programming of resident stem/progenitor cells into cardiomyocytes, both in vitro and in vivo. Such methods find particular use in the treatment of patients post-myocardial infarction to prevent or limit scarring and to promote myocardial repair.

Abstract: The present disclosure describes the role for miR-322(424)/503 in the differentiation of cardiac precursor cells. Thus, the use of these molecules in the programming of resident stem/progenitor cells into cardiomyocytes, both in vitro and in vivo. Such methods find particular use in the treatment of patients post-myocardial infarction to prevent or limit scarring and to promote myocardial repair.

Abstract: The present disclosure describes the role for miR-322(424)/503 in the differentiation of cardiac precursor cells. Thus, the use of these molecules in the programming of resident stem/progenitor cells into cardiomyocytes, both in vitro and in vivo. Such methods find particular use in the treatment of patients post-myocardial infarction to prevent or limit scarring and to promote myocardial repair.

Abstract: According to an example, a first terminal device uploads sharing information to a server, the server sends identification information related to the sharing information to the first terminal device according to the sharing information, and the first terminal device transforms the identification information into a sound signal, and plays the sound signal. a second terminal device receives the sound signal, parses the sound signal to obtain the identification information, and sends a download request comprising the identifier information to the server. The server sends the sharing information to the second terminal device according to the download request.

Abstract: The present disclosure describes the role for miR-322(424)/503 in the differentiation of cardiac precursor cells. Thus, the use of these molecules in the programming of resident stem/progenitor cells into cardiomyocytes, both in vitro and in vivo. Such methods find particular use in the treatment of patients post-myocardial infarction to prevent or limit scarring and to promote myocardial repair.

Abstract: A method and apparatus for editing an application webpage, including prestoring information of a function and configuration data corresponding to the function; generating a webpage design, monitoring that shortcut area edit is triggered, obtaining shortcut area information inputted by a user, obtaining size of a shortcut area and position information corresponding to the shortcut area according to the shortcut area information; receiving function data inputted by the user according to preconfigured configuration data corresponding to the selected function, encapsulating the function data, the size of the shortcut area and the position information corresponding to the shortcut area into a data file; loading a running environment of the data file, creating a webpage shortcut area according to the size of the shortcut area and the position information corresponding to the shortcut area included in the data file; and extracting the function data in the data file, generating page function codes corresponding to th